| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.84B | 29.09B | 30.55B | 29.22B | 28.45B | 22.24B |
| Gross Profit | 13.62B | 12.41B | 13.73B | 12.07B | 11.89B | 8.70B |
| EBITDA | 6.87B | 5.96B | 7.05B | 5.94B | 6.02B | 3.58B |
| Net Income | 3.96B | 4.34B | 3.81B | 3.13B | 4.00B | 1.99B |
Balance Sheet | ||||||
| Total Assets | 40.83B | 40.20B | 42.40B | 42.04B | 41.60B | 39.00B |
| Cash, Cash Equivalents and Short-Term Investments | 12.62B | 11.72B | 13.89B | 14.31B | 16.14B | 14.44B |
| Total Debt | 708.06M | 391.25M | 586.07M | 1.13B | 1.41B | 731.80M |
| Total Liabilities | 8.35B | 7.97B | 8.89B | 9.57B | 10.09B | 8.71B |
| Stockholders Equity | 31.68B | 31.35B | 32.74B | 31.85B | 31.09B | 30.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.97B | 2.95B | 1.61B | 4.49B | 2.87B |
| Operating Cash Flow | 0.00 | 2.70B | 3.94B | 2.40B | 4.85B | 3.77B |
| Investing Cash Flow | 0.00 | 835.47M | 1.47B | -2.97B | 281.92M | -1.47B |
| Financing Cash Flow | 0.00 | -5.90B | -4.71B | -4.08B | -3.71B | -1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥65.90B | 7.90 | ― | 3.95% | 2.75% | 25.75% | |
80 Outperform | ¥73.11B | 12.40 | ― | 2.63% | 2.11% | 0.91% | |
74 Outperform | ¥41.02B | 10.49 | ― | 3.95% | -4.76% | 20.37% | |
73 Outperform | ¥56.50B | 13.82 | ― | 2.54% | 3.47% | -12.26% | |
66 Neutral | ¥30.60B | -301.11 | ― | 2.13% | 0.12% | 59.33% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥6.59B | 4.63 | ― | 1.37% | -5.11% | 29.29% |